<HashMap><database>biostudies-other</database><scores/><additional><submitter>Thorner AR</submitter><pagination>742-751</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-ECPF-GEOD-11429</full_dataset_link><project>EurocanPlatform</project><abstract>The basal-like breast cancer subtype portends a poor clinical prognosis, and a defining feature of this subtype is the high expression of genes in the “proliferation signature”.  B-Myb, a member of the MYB protein family of transcription factors, is highly expressed in the proliferation signature and is amplified and overexpressed in a variety of tumor types, including breast.  In this report we demonstrated that B-Myb is highly expressed in basal-like breast cancer relative to the other subtypes, and B-Myb expression alone is prognostic. We also identified an association between a nonsynonymous B-Myb germline variant (S427G, rs2070235) and an increased risk of having a basal-like breast cancer among patients with breast cancer.  The expression of B-Myb, or the S427G variant, was manipulat</abstract><repository>biostudies-other</repository><experiment_type>transcription profiling by array</experiment_type><data_source>EurocanPlatform</data_source><omics_type>Unknown</omics_type><volume>28</volume><journal>Oncogene</journal><species>Homo sapiens</species><pubmed_authors>Millikan RC</pubmed_authors><pubmed_authors>Winkel S</pubmed_authors><pubmed_authors>Hoadley KA</pubmed_authors><pubmed_authors>Parker JS</pubmed_authors><pubmed_authors>Thorner AR</pubmed_authors><pubmed_authors>Perou CM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcription profiling of human basal-like breast cancer - in vitro and in vivo Analysis of B-Myb</name><description>The basal-like breast cancer subtype portends a poor clinical prognosis, and a defining feature of this subtype is the high expression of genes in the “proliferation signature”.  B-Myb, a member of the MYB protein family of transcription factors, is highly expressed in the proliferation signature and is amplified and overexpressed in a variety of tumor types, including breast.  In this report we demonstrated that B-Myb is highly expressed in basal-like breast cancer relative to the other subtypes, and B-Myb expression alone is prognostic. We also identified an association between a nonsynonymous B-Myb germline variant (S427G, rs2070235) and an increased risk of having a basal-like breast cancer among patients with breast cancer.  The expression of B-Myb, or the S427G variant, was manipulat</description><dates><release>2016-04-14T13:28:26Z</release><publication>2009 Feb</publication><modification>2016-04-14T13:28:26Z</modification><creation>2016-04-14T13:28:26Z</creation></dates><accession>S-ECPF-GEOD-11429</accession><cross_references><GEO>GSE11429</GEO><ArrayExpress>E-GEOD-11429</ArrayExpress><EFO>EFO_0000305</EFO><EFO>EFO_0000322</EFO><ArrayExpress files>E-GEOD-11429</ArrayExpress files></cross_references></HashMap>